For the second consecutive year, Ergon is supporting financially the Kick Cancer Fund, a fund dedicated to research in paediatric oncology managed by the King Baudouin Foundation.

Kick Cancer Fund finances clinical trials on innovative drugs with the view to improve our understanding of the origin and functioning of paediatric cancers, which will allow, in the long run, the development of new drugs for paediatric cancers.